Full Text View
Tabular View
No Study Results Posted
Related Studies
Dabigatran Etexilate in Extended VTE Prevention After Hip Replacement Surgery
This study has been completed.
Study NCT00168818   Information provided by Boehringer Ingelheim Pharmaceuticals
First Received: September 12, 2005   Last Updated: September 29, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Thromboembolism
Arthroplasty, Replacement, Hip
More general conditions related to this trial
Cardiovascular Diseases
Embolism and Thrombosis
Thrombosis
Vascular Diseases
Sponsors listed in this trial
Boehringer Ingelheim Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services